• English (English)
Locust Walk
  • About Us
    • Overview
      • Capabilities
      • Geographies
      • Industry Segments
    • Our Team
      • Deal Professionals
      • Advisory Board
      • Operations Team
  • Our Clients
    • Biopharma
    • Medtech
  • Our Transactions
  • Insights
    • Thought Leadership
    • Webinars & Panels
    • Podcast
    • News
  • Careers
    • Careers
    • Our Core Values
    • Our Culture
  • Contact Us
Select Page

InterMune Divests Actimmune to Vidara Therapeutics

May 10, 2012

The Locust Walk team is proud to share with you today’s news of our client, InterMune’s, divestiture of Actimmune® (interferon gamma-1b) to Vidara Therapeutics.


 

Related Posts

  • Biotalk Episode 2: Bradley Campbell, Amicus Therapeutics
  • Hello world!
  • Cortendo adds two late‐stage assets and announces $33M financing

Categories

  • News
  • Events
  • Publications

Archive

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008

BOSTON

200 Clarendon Street
51st Floor
Boston, MA 02116

info@locustwalk.com

SAN FRANCISCO

499 Illinois Street
Suite 200
San Francisco, CA 94158

415.579.0090 Office

Privacy Policy

TOKYO

PMO Nihonbashi Muromachi 3F
1-13-7 Nihonbashi Muromachi
Chuo-ku, Japan 103-0022

+81 3 6665 0707 Office

LONDON

Kemp House
152-160 City Road
London EC1V 2NX

 

  • LinkedIn
  • Twitter

Designed by Gill Fishman Associates